Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Clin Cancer Res. 2014 Jun 19;20(15):3974–3988. doi: 10.1158/1078-0432.CCR-14-0011

Table 1.

CD44 score, progression, and survival

Status N % CD44 score mean±SD p value

All patients No progression 27 27.8 35.7±56.6 0.473
Definite progression 70 72.2 46.1±66.3

Alive 24 26.4 44.4±56.8 0.804
Dead 67 73.6 40.7±64.4

Chemotherapy only No progression 15 29.4 20.7±29.9 0.011
Definite progression 36 70.6 60.3±76.6

Alive 12 25.0 24.2±28.7 0.041
Dead 36 75.0 55.4±73.8

Chemotherapy plus
Vismodegib
No progression 12 26.1 54.6±75.8 0.233
Definite progression 34 73.9 31.2±50.1
Alive 12 27.9 64.6±70.9 0.032
Dead 31 72.1 23.6±47.0